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Abstract 
Dietary patterns with substantial proportions of energy from plant sources have been associated with 
favorable biomarkers of low-grade inflammation. Less is known of the relation between vegetarian-based 
dietary patterns and markers of inflammation and immune status. This systematic review and meta-
analysis aimed to determine the relation between vegetarian-based dietary patterns and inflammatory 
and immune markers (C-reactive protein, tumour necrosis factor α, fibrinogen, natural killer cells, 
leukocytes, lymphocytes, thrombocytes, interleukins, and immunoglobulins). PubMed, Medline, and 
Cochrane scientific databases were searched to identify relevant studies. Random effects meta-analyses 
were conducted to assess the weighted mean differences (WMDs) for each outcome variable between 
vegetarian and non-vegetarian groups. Thirty observational and 10 intervention studies were included in 
the review. Pooled effects of vegetarian-based dietary patterns were associated with significantly lower 
concentrations of CRP (WMD: -0.61 mg/L; 95% CI: -0.91, -0.32 mg/L; P = 0.0001), fibrinogen (WMD: -0.22 
g/L; 95% CI: -0.41, -0.04 mg/L; P = 0.02), and total leukocyte (WMD: -0.62 x 103/μL; 95% CI -1.13 x 103, 
-0.10 x 103/μL; P = 0.02) compared with those following non-vegetarian dietary patterns in observational 
studies. Insufficient data were identified for a meta-analysis of intervention studies. This study provides 
evidence that vegetarian-based dietary patterns are associated with lowered serum C-reactive protein, 
fibrinogen, and total leukocyte concentrations. Future research should focus on large-scale intervention 
trials, contrasting differences in inflammation and immune status and function between vegetarian and 
non-vegetarian-based populations. 
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Abstract 38 
Dietary patterns with substantial proportions of energy from plant sources have been 39 
associated with favorable biomarkers of low-grade inflammation. Less is known of the 40 
relation between vegetarian-based dietary patterns and markers of inflammation and immune 41 
status. This systematic review and meta-analysis aimed to determine the relation between 42 
vegetarian-based dietary patterns and inflammatory and immune markers (C-reactive protein; 43 
(CRP), tumour necrosis factor-alpha (TNF-α), fibrinogen, natural killer cells, leukocytes, 44 
lymphocytes, thrombocytes, interleukins and immune globulins). PubMed, Medline and 45 
Cochrane scientific databases were searched to identify relevant studies. Random effects 46 
meta-analyses were conducted to assess the weighted mean differences (WMD) for each 47 
outcome variable between vegetarian and non-vegetarian groups. Thirty observational and 48 
ten intervention studies were included in the review. Pooled effects of vegetarian-based 49 
dietary patterns were associated with significantly lower concentrations of CRP (WMD: -0.61 50 
mg/L; 95% CI: -0.91, -0.32; P = 0.0001), fibrinogen (WMD: -0.22 g/L; 95% CI: -0.41, -0.04; 51 
P = 0.02) and total leukocyte (WMD: -0.62 x103/μL; 95% CI -1.13, -0.10; P = 0.02) 52 
compared to those following non-vegetarian dietary patterns in observational studies. 53 
Insufficient data was identified for a meta-analysis of intervention studies. This study 54 
provides evidence that vegetarian-based dietary patterns are associated with lowered serum 55 
CRP, fibrinogen and total leukocyte concentrations. Future research should focus on large 56 
scale intervention trials, contrasting differences in inflammation and immune status and 57 
function between vegetarian and non-vegetarian based populations.  58 
 59 
Keywords: Inflammation; immune function; vegetarian; vegan; diet; dietary patterns; CRP; 60 
IL-6; meta-analysis; systematic review.  61 
 62 
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Introduction  63 
Nutritional epidemiology has seen a shift away from single nutrient analyses to a 64 
complementary approach in the form of dietary pattern analysis (1). Evaluating dietary 65 
patterns may provide a more holistic and clinically relevant approach to assessing diet-66 
disease relation as nutrients are not eaten in isolation and synergistic effects of multiple 67 
components can have a concerted effect (2). Vegetarian-based dietary patterns are typically 68 
higher in fruits, vegetables, wholegrains, nuts, seeds and legumes, all of which are naturally 69 
higher in phytochemicals and some vitamins compared to non-vegetarian dietary patterns (3, 70 
4). A variety of vegetarian-based eating patterns exist based on the inclusion and/or exclusion 71 
of animal products. For example, individuals who omit all animal products are classically 72 
described as vegan, whilst those who include eggs and dairy products are referred to as lacto-73 
ovo-vegetarian (LOV) (5). Consumption of these dietary patterns are protective against many 74 
chronic diseases including; coronary heart disease, type 2 diabetes mellitus (T2DM), some 75 
cancers and associated with lower all-cause mortality (6-9). 76 
An array of mechanisms are likely responsible for the protective effects observed in 77 
vegetarian-based dietary patterns, including improved inflammatory and immune responses. 78 
These systems can be modulated by various dietary patterns and food components, 79 
demonstrating that plant-based foods can provide favorable outcomes (10-13). When 80 
considering inflammation, and immune status, it is important to recognize that these systems 81 
are inherently linked and work synergistically. For instance, C-reactive protein (CRP), a non-82 
specific systemic marker of inflammation may be elevated in response to cytokines released 83 
by phagocytes during an infection or tissue damage (14). 84 
Without a sufficient exogenous supply of nutrients the immune system will be jeopardized 85 
(15). In addition, the impact of ‘non-nutritive’ components of food on immune function has 86 
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been acknowledged (16-18). For example, polyphenolic compounds are shown to improve 87 
lymphocyte responsiveness and natural killer cell function (19)  while carotenoids can have 88 
an immune modulating effect (20). When considering the implications of these findings, it 89 
should be noted that we do not consume these components in isolation (2). As such, 90 
exploration of the impact of consuming a whole dietary pattern that is likely to be high in 91 
these components seems indicated. 92 
The influence of diet on inflammation has also been examined with clear associations found 93 
(12, 21). The inflammatory response is a complex biological response used for protection 94 
against mechanical, environmental and/or pathological challenges and is associated with 95 
intracellular signalling molecules which can influence both immune and inflammation 96 
responses (22, 23). Research has demonstrated links between chronic low-grade 97 
inflammation and increased risk of various diseases, with inflammation hypothesized as an 98 
underlying pathophysiological mechanism. For instance, chronic elevation of the 99 
inflammatory markers CRP, Interleukin-6 (IL-6) and fibrinogen are shown to predict risk of 100 
cardiovascular disease (24), all-cause mortality (25), T2DM(26) and some cancers (27). 101 
There is evidence to suggest that plant-based diets may have favorable effects on 102 
inflammation. Consumption of dietary patterns with substantive nutrients obtained from plant 103 
sources compared to animal sources have been shown to attenuate markers of chronic 104 
inflammation such as CRP, Interlukin-6 (IL-6) and fibrinogen (12, 13, 21, 28). Similarly, a 105 
meta-analysis recently suggested that vegetarianism was associated with lowered serum CRP 106 
concentrations and may be a useful dietary approach to manage ‘inflammaging’, or the 107 
increased levels of chronic inflammation associated with aging (29). However, the review 108 
may be impacted by their inclusion of participants using statins (which can effect 109 
inflammatory markers such as CRP (30, 31)) and inclusion of intervention groups which may 110 
have incorporated consumption of some meat. In addition, consideration of the evidence base 111 
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from randomized controlled trials (RCT’s) is required to explore the effect of consuming a 112 
plant-based diet, hereon in referred to as a vegetarian-based, on specific inflammatory and 113 
immune markers.  114 
This systematic literature review aims to determine if vegetarian-based eating patterns in 115 
humans is associated with, or able to modulate, inflammation or immune biomarkers 116 
compared to those following non-vegetarian dietary patterns? A meta-analysis will further 117 
explore the effect of vegetarian-based eating patterns on common inflammation and/or 118 
immune biomarkers compared to non-vegetarian dietary patterns. 119 
 120 
Methods 121 
Study protocol 122 
The systematic review followed the requirements of the Preferred Reporting of Systematic 123 
Reviews and Meta-analyses (PRISMA) statement (32) and was registered with the 124 
International Prospective Register of Systematic Reviews (PROSPERO, CRD42016039043; 125 
12 May 2016). A systematic search of the Pubmed, MEDLINE and Cochrane Central 126 
Register of Controlled Trials scientific databases (all years to December 2017) was conducted 127 
to answer the research question. Scientific database searches were conducted by one reviewer 128 
(JC). The search strategy used the following key words, with Medical Subject Heading terms 129 
used where available: (“Immunoglobulin*” OR “IgE” OR “IgD” OR “IgM” OR “IgA” OR 130 
“IgG” OR “Platelet*” OR “Basophil*” OR “Eosinophil*” OR "t lymphocyte subsets" OR “t 131 
cell*” OR "b lymphocyte subsets OR “B cell*” OR “Monocyte*” OR “Neutrophil*” OR 132 
“Lymphocyte*” OR “Leukocyte*” OR "white blood cell*" OR “NK” OR "natural killer t 133 
cell*" OR "natural killer cell*" OR "immunity" OR “immune” OR “tumor necrosis factor” 134 
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OR "tumour necrosis factor" OR “TNF” OR “interleukin” OR “IL-6 “ OR “fibrinogen” OR 135 
OR “CRP” OR "c reactive protein" OR “C-Reactive Protein” OR “inflammat*”) AND ("plant 136 
based" OR "plant-based" OR “vegan*” OR “*vegetarian” OR “vegetarian*”). An example of 137 
the search strategy in its entirety is shown in Supplemental Table 1. This review considered 138 
any dietary pattern including animal meats (including fish) to be non-vegetarian-based while 139 
dietary patterns excluding all animal meats to be vegetarian-based. 140 
Inclusion criteria 141 
Studies were included if they examined the relationship (observational studies) or effect 142 
(intervention studies) of vegetarian-based dietary patterns compared to a non-vegetarian-143 
based control dietary pattern on an outcome of interest (CRP, interleukins (all), TNF (all), 144 
fibrinogen, natural killer cells, white blood cell counts (Leukocytes, Lymphocytes, 145 
Neutrophils, Monocytes, Eosinophils, Basophils, Thrombocytes), Immune globulins (IgG, 146 
IgA, IgE, IgD and IgM), and were conducted in human populations of all ages.  147 
Observational studies were defined a priori to include any studies in which there was no 148 
direct intervention and could include; cross-sectional, case-control, prospective cohort and 149 
retrospective cohort studies. They had to additionally; involve participants who had adhered 150 
to a vegetarian-based diet (vegetarian group only) for at least 1 year. This timeframe was 151 
chosen to represent a habitual dietary pattern.  152 
Intervention studies were also defined a priori to include any studies where a vegetarian-153 
based diet was used as an intervention with a control group and could include randomized 154 
controlled trials, non-randomized controlled trials and pre-post studies. Intervention studies 155 
had to additionally; study the vegetarian-based diet for a period exceeding 4 weeks. This 156 
timeframe was selected as changes in some serum inflammatory markers such as IL-6 and 157 
CRP can take several weeks to become physiologically apparent (33-35).  158 
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Exclusion criteria 159 
Observational and intervention studies were excluded if they;  160 
i) were not published in the English language 161 
ii) were conference abstracts, editorials, book series, erratum and conference 162 
proceedings  163 
iii) did not complete between group analyses or provide raw data to allow this to be 164 
calculated 165 
iv) were animal or cellular models  166 
v) were analysing consumption of single foods or food groups rather than dietary 167 
patterns (e.g. exploring legume intake rather than vegetarian diets).  168 
vi) used drugs which could alter biomarker outcomes i.e. metformin (CRP) (30, 31) 169 
vii) were assessing antibodies to food antigens rather than disease or general blood 170 
immunoglobulins. 171 
viii) included any type of animal meat (including fish) in the vegetarian-based groups  172 
ix) examined a single diet component/supplement only (e.g. cheese vs vegan cheese 173 
alternate)  174 
Intervention studies were additionally omitted if they;  175 
(i) used lifestyle interventions in conjunction with diet intervention i.e. exercise 176 
and/or stress management  177 
(ii) used intervention diets containing any type of meat and/or not reporting to 178 
control/discouraged meat intake  179 
Duplicate articles were initially removed using EndNote referencing software (version X7, 180 
2013 Thomson Reuters; Philadelphia, Pennsylvania) with any remaining duplicated removed 181 
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manually. Articles were firstly screened based on title and abstract. Full text articles were 182 
obtained if the abstract was unavailable, or if it was unclear if the article met the inclusion 183 
criteria. Screening was performed by reviewer JC with articles of concern discussed amongst 184 
the research team (YP, EN, GP) until consensus was reached. Where results from the same 185 
study were reported in multiple articles, the most recent article was included to avoid 186 
duplication of results. Reference lists of included articles were hand-searched to identify 187 
additional relevant articles.  188 
Data extraction 189 
Data extraction was performed by reviewer JC in consultation with the research team and 190 
included information related to: author, date, study design, level of evidence, study 191 
population (including age, gender, country and co-morbidities), sample size, length of 192 
vegetarianism (observational studies), type of vegetarianism, details of intervention and 193 
control groups (intervention studies), outcomes investigated and significant differences in 194 
biomarkers. Study authors were contacted for additional details if the required data was not 195 
available in the published article. 196 
Statistical analysis 197 
Meta-analysis were performed when more than three studies reported on a biomarker, 198 
median/mean with standard deviation could be obtained or calculated from raw data and the 199 
units of measurement could be made uniform. Meta-analyses were conducted separately for 200 
observational and intervention study results. Review Manager software (Review Manager 201 
(RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, the Cochrane 202 
Collaboration, 2014) was used to estimate the pooled effect of inflammation and immune 203 
markers between vegetarian and non-vegetarian diets. Random effect meta-analyses were 204 
conducted to determine weighted mean differences by assigning a weight to each study on the 205 
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basis of an individual study’s inverse variance (36). 95% confidence intervals were used for 206 
each outcome. If a study involved more than one intervention group meeting the inclusion 207 
criteria, data for all intervention groups were combined as recommended by the Cochrane 208 
Handbook (37). For the intervention analysis, cross-over studies were initially analysed as 209 
parallel studies using a paired analysis, the most conservative approach to managing cross-210 
over studies (37). Paired analyses of cross-over studies using correlation coefficients of 0.25, 211 
0.5 and 0.75 were then conducted as sensitivity analyses to determine if this influenced the 212 
results (37). The I2 statistic was used to evaluate heterogeneity with a score 50 - 90% likely 213 
indicating substantial heterogeneity and a score of 75% - 100% considerable heterogeneity 214 
(37). Where ≥ 10 studies reported on a biomarker outcome, funnel plots were generated and 215 
Egger’s test applied to assess studies for small study effects (38) using StatsDirect statistical 216 
software (Version 3.1, England: StatsDirect Ltd, England, 2013) (39).  217 
Where median and ranges were reported, the Hozo et al formula was used to calculate 218 
standard deviation and/or mean (when the population was < 25 persons) (40). When 219 
interquartile range (IQR) was given, IQR /1.35 was used to calculate standard deviation (37). 220 
Where insufficient information was described in the published article and raw data was 221 
provided by authors, statistical analyses were performed using SPSS software (v21, SPSS 222 
Inc, Chicago, Il 2012). Shapiro-Wilk tests on raw data determined if biomarker outcomes 223 
were normally distributed. One-way ANOVA (parametric) or Kruskal-Wallis (non-224 
parametric) tests determined if differences existed between dietary patterns for inclusion in 225 
the summary table. P values < 0.05 were considered to be statistically significant.  226 
Sensitivity analyses were performed by excluding each study individually to investigate the 227 
influence on overall estimates (37). Additionally, sensitivity analyses were conducted by 228 
excluding studies where participants suffered from a chronic condition. When sufficient data 229 
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was available for type of vegetarianism (LOV or vegan dietary patterns) (≥ 3 studies) sub-230 
group analyses were performed.  231 
Risk of bias  232 
Study quality for the non-randomized studies was assessed independently using a modified 233 
version of the Newcastle-Ottawa Scale (NOS) by two reviewers (J.C, E.N). Where 234 
discrepancies occurred, a third reviewer (Y.P) was consulted until a consensus was reached. 235 
The NOS for each study was based on the primary outcome of the present study (CRP) if 236 
available. For intervention studies, risk of bias was assessed using the Cochrane 237 
Collaboration’s tool (37). To determine the quality of the body of evidence, the Grading of 238 
Recommendations Assessment, Development and Evaluation (GRADE) method was applied 239 
to both observational and intervention studies (41).  240 
 241 
Results 242 
The literature search identified 2040 articles. After the exclusion criteria were applied, 39 243 
studies (30 observational articles (42-71) describing 29 studies (two separate articles were 244 
identified reporting on same study participants, with different outcome marker/s) and 8 245 
intervention studies) were included in the review. A further 2 studies were identified via hand 246 
searching reference lists, resulting in a total of 10 intervention studies (72-81). Figure 1 247 
displays the complete process of study selection including identification, screening, 248 
eligibility, and inclusion.  249 
Observational Studies 250 
Description of the included studies 251 
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The included studies were cross-sectional or matched cohort studies (Table 1). Types of 252 
vegetarianism included LOV (8), Lacto-vegetarian (2), vegan (5) and combinations of these 253 
with comparison groups typically consuming mixed omnivorous non-vegetarian diets. 254 
Participants in two of the included studies had chronic conditions with one receiving dialysis 255 
therapy (59, 70) while participants in the other study had cardiovascular disease and/or 256 
diabetes mellitus (63). One study (63) reported on participants whose age ranged between 2-257 
18 years old whilst the remainder reported on adults aged 18 years or older (Table 1). Studies 258 
were conducted in a range of continents including: Asia (44-46, 59, 62, 63, 66-71), 259 
Africa(49) North America (47, 50, 51, 54, 60), South America (42, 48, 52, 57) and Europe 260 
(43, 53, 55, 56, 58, 61, 64, 65). Study quality ranged from 2-6 out of a possible seven using 261 
the modified NOS tool (Supplemental Table 2).  262 
CRP concentrations were significantly lower in 9/19 studies in the vegetarian-based groups, 263 
with no difference in 10/19 studies (42-46, 50-52, 54, 55, 57, 59, 60, 64-66, 68, 70, 71). 264 
Leukocyte counts were significantly lower in 6/11 studies in the vegetarian-based groups 265 
with no difference in 5/11 studies (44, 45, 47, 48, 54, 56, 62, 64, 67, 69, 70) (Table 2). Four 266 
studies reported on lymphocyte counts with vegetarian-groups displaying significantly lower 267 
counts in two of the studies (54, 56, 62, 69). Only two studies reported on NK cell cytotoxic 268 
activity as a function of applied immune-competence and found improved function in the 269 
vegetarian-based group (56) or no difference between groups (54). One study reported lower 270 
neutrophil counts in vegetarian-based groups (48), while the other three studies found no 271 
difference between groups (54, 62, 69). Fibrinogen was observed to be lower in vegetarian-272 
based groups in 2/3 studies (49, 57, 67). Table 2 shows the number of included studies 273 
identified for each biomarker and summarizes the number of studies reporting significant and 274 
non-significant differences in outcomes between vegetarian and non-vegetarian groups.  275 
Relation between vegetarian-based diets on inflammatory and immune biomarkers 276 
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Twenty-Six observational studies were included in the meta-analysis reporting on four 277 
outcomes; CRP, thrombocytes, leukocytes, and fibrinogen (Table 3). Consumption of a 278 
vegetarian-based dietary pattern was associated with significantly lower CRP (P = 0.001; 279 
Figure 2), fibrinogen (P = 0.02; Figure 3) and leukocyte (P = 0.02; Figure 4) levels 280 
compared to those following a mixed omnivorous non-vegetarian comparison diet. No 281 
significant difference was observed for thrombocytes between groups (P = 0.16; Figure 5). 282 
The quality of body of evidence for the observational studies was deemed to be ‘very low’ 283 
after a one level downgrade was applied for each outcome as per the GRADE guidelines (41) 284 
(Supplemental Table 3). Funnel plots were generated for CRP and leukocyte concentrations. 285 
Egger’s test indicated no significant asymmetry (Supplemental Figure 1).  286 
 287 
Sensitivity analysis and subgroup analysis  288 
When sensitivity analyses were applied, the pooled effect on CRP remained significant. The 289 
pooled effect on leukocytes became non-significant when Pongstaporn et al (62) was omitted 290 
(P = 0.08). Conversely, thrombocytes were significantly higher in the vegetarian group with 291 
the omission of Haddad et al (54) (P = 0.01) (Supplemental Figure 2). Lower leukocyte and 292 
CRP levels in vegetarian-based populations continued to be found when sensitivity analyses 293 
were applied excluding studies with participants receiving haemodialysis treatment, 294 
cardiovascular disease (CVD) and/or T2DM (0.01) (Supplemental Figure 3).  295 
Due to considerable heterogeneity observed (I2 = 100%) for CRP concentrations between 296 
dietary groups, meta-analyses were performed on specific dietary groups in an attempt to 297 
identify the source of heterogeneity. No significant sub-group differences were observed 298 
between vegan, LOV groups and non-vegetarian groups for CRP. Neither sub-group analysis 299 
accounted for the high heterogeneity (I2 for both vegan and LOV groups 87%; Supplemental 300 
Figure 4).301 
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Intervention Studies 302 
Ten intervention studies were identified exploring the effect of vegetarian-based eating 303 
patterns on common markers of inflammation and/or immune function (72-81). They 304 
included seven parallel and three crossover intervention study designs. Of the included 305 
studies, seven were randomized (72-77, 81), and the remaining three were unable to be 306 
confirmed as being randomized or non-randomized (78-80) as authors could not be contacted. 307 
Vegetarian-based intervention diets included LOV (n=3), LV (n=1) and vegan (n=6) with 308 
varying macronutrient percentages (Table 4). Control diets varied and included; a well-309 
balanced mixed diet from the five food groups (72), a conventional T2DM diet recommended 310 
by the European Association for the Study of Diabetes (73), habitual mixed diets (74, 75, 77, 311 
79, 80), and an American Heart Association diet (Fat total 30%, 7%  saturated fat, < 300 mg 312 
of cholesterol, < 1500 mg of sodium daily) (76). Intervention diet duration ranged from four 313 
to 56 weeks. Studies were from North America (76, 81) and Europe (72-75, 77-80). The 314 
populations examined in the included studies were mixed. For instance, in four studies the 315 
participants had rheumatoid arthritis, one study population exhibited T2DM, one study 316 
participants were overweight or obese (class 1; as measured by BMI) and one study 317 
participants were children > 95% of BMI for age. Biomarkers investigated varied between 318 
studies (Table 4).  319 
CRP levels were found to be significantly lower in vegetarian-based groups compared to non-320 
vegetarian groups in 4/7 studies, with no significant difference in 3/7 intervention studies 321 
(Table 5). Lymphocytes, monocytes, Pan T cells (CD3+), T suppressor cells (CD8+), T 322 
helper cells (CD4+), NK cells, TNF-α, fibrinogen, IL-6 and IgA were reported by only one 323 
intervention study, with no significant difference between vegetarian and non-vegetarian 324 
groups found. Table 5 shows a summary of the included intervention studies and 325 
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corresponding biomarker outcomes with significant and non-significant differences between 326 
study groups. The quality of body of evidence for the intervention studies was rated as ‘very 327 
low’ according to GRADE (Supplemental Figure 5) (41).  328 
Pooled effects and subgroup analysis of vegetarian-based diets on inflammatory and immune 329 
biomarkers 330 
Of the 10 studies identified, only four studies were eligible for a meta-analysis examining 331 
vegetarian-based dietary patterns and their effect on CRP (vegetarian [n = 116], non-332 
vegetarian [n = 114]). Due to the small population pool, varied population demographics 333 
(patients with rheumatoid arthritis, women, children with a BMI > 95th % for age/sex with 334 
cholesterol >169mg/dL and patients with T2DM), and varying intervention diets, the meta-335 
analysis has been included as supplementary data to avoid potentially misleading conclusions 336 
common in nutritional meta-analyses (82) (Supplemental Figure 6). The Cochrane risk of 337 
bias assessment (Supplemental Table 4) and risk of bias graph (Supplemental Figure 7) are 338 
available as supplementary data. As a result of insufficient data and/or studies, it was not 339 
possible to perform meta-analyses for the other outcomes.  340 
Discussion  341 
To the authors’ knowledge, this review and meta-analysis is the first to explore both the 342 
association and effect of consuming a vegetarian-based dietary pattern on biomarkers of 343 
inflammation and immune status. The results of the analysis of observational studies suggest 344 
that individuals following vegetarian-based diets may have lower levels of CRP and 345 
fibrinogen, two prominent markers of inflammation, compared to their non-vegetarian based 346 
counterparts. Given CRP is implicated in the development of atherosclerosis (83) and is an 347 
independent risk predictor of cardiovascular events (84, 85), the results of this review may 348 
partly explain the lowered incidence of cardiovascular events observed in vegetarian 349 
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populations (86, 87). The lowered leukocyte and fibrinogen concentrations observed in 350 
vegetarian-based eating patterns appears to be favorable as elevated leukocyte and fibrinogen 351 
biomarkers have been associated with increased risk of all-cause mortality (88), T2DM (89), 352 
metabolic syndrome (90) and coronary heart disease (91).  353 
Our results are in contrast to those of a recent meta-analysis, which found non-significant 354 
differences in CRP concentrations between vegetarian and non-vegetarian-based dietary 355 
patterns (Hedges’ g = −0·15; 95% CI: 0·35, 0·05)(29). There are several explanations for the 356 
inconsistency. Firstly, the present review excluded studies where statins were used by 357 
participants as they are known to reduce inflammation (30, 31) whereas the previous analysis 358 
included one study where statin use was significantly different between groups (92). 359 
Secondly, the previous review (29) included studies that included small amounts of animal 360 
flesh in the vegetarian group (93) or where the vegetarian dietary pattern was not adequately 361 
described (94), whereas these studies were excluded from our review. We also only included 362 
studies with a duration of vegetarianism of 1 year or longer, aligning with the suggestion that 363 
there may be a time interval between starting a vegetarian diet and reduction in CRP (29). 364 
Finally, this review has included recently published studies not available at the time of the 365 
previous review (42, 43, 52). 366 
Despite ten intervention studies identified for inclusion in this review, many biomarkers of 367 
interest were not reported upon, or only explored in a single study thereby limiting 368 
conclusions regarding the effect of vegetarian-based dietary patterns on these outcomes. CRP 369 
was explored in seven studies however, with significantly lowered concentrations following 370 
consumption of a vegetarian-based diet observed in 4/7 studies, which aligns with the results 371 
of the observational meta-analysis presented here. The limited body of evidence identified in 372 
the intervention studies highlights the need for further RCT’s to confirm the results of the 373 
observational meta-analysis.  374 
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An array of nutrients and ‘non-nutritive’ components of the vegetarian diet may be 375 
responsible for the trend for lowered inflammation biomarkers following consumption of a 376 
vegetarian-based dietary pattern (95). Consumption of flavonoids such as quercetin, 377 
kaempferol, malvidin, peonidin, daidzein, and genistein have been inversely associated with 378 
serum CRP even after adjustment for covariates including vitamin C, vitamin E, carotenes, 379 
and fruit and vegetable consumption (96). The antioxidant properties of flavonoids have been 380 
hypothesized to prevent LDL oxidation - an early inflammatory event in the development of 381 
atherosclerosis  (97). Similarly, carotenoids are potent antioxidants embedded within the lipid 382 
bi-layer functioning to appease free radicals and have been inversely associated with markers 383 
of inflammation (98, 99). Both flavonoids and carotenoids are typically found in higher 384 
concentrations in those following vegetarian-based dietary patterns (100) and may contribute 385 
to the observed attenuation of inflammation in vegetarian-based groups. Phytochemicals, 386 
which tend to be more plentiful in vegetarian-based eating patterns (100), may act as 387 
antioxidant, antibacterial, antifungal, anti-inflammatory, antiallergic, hypotensive, chemo-388 
preventive agents (11, 101), and may modulate inflammatory and immune function (11, 17, 389 
18). Quantifying phytochemical intakes between vegetarian and non-vegetarian groups may 390 
be a target for future research.  391 
Type and quantity of dietary fat intake may also influence low-grade inflammation 392 
concentrations. Several studies have linked dietary saturated fatty acids with increased serum 393 
hs-CRP and fibrinogen levels (102, 103). Saturated fatty acid intake is typically higher in 394 
non-vegetarian based dietary patterns due to the increased consumption of animal based 395 
products (100) and may contribute to the increased concentration of serum CRP and 396 
fibrinogen observed in non-vegetarian based populations. Vegetarian-based populations 397 
typically consume a greater proportion of their dietary fat in the form of unsaturated fatty 398 
17 
 
acids compared to non-vegetarians (104) which are inversely associated with inflammation 399 
(105).  400 
It is important to note that overweight and obesity are associated with elevated inflammation 401 
markers including  TNF-α and IL-6 (106). Vegetarian-based populations typically exhibit 402 
lower BMI’s than non-vegetarian populations (107) which may in part account for the 403 
reduced CRP, fibrinogen and total leukocyte concentrations in the vegetarian-based 404 
compared to the non-vegetarian based populations observed in this review. 405 
Due to the limited number of studies, quantitative analysis was not possible for many 406 
biomarkers in both observational and intervention studies including interleukins (all), TNF-α, 407 
NK cell activity, lymphocytes, neutrophils, monocytes, eosinophils, basophils, IgG, IgA, IgD, 408 
IgE and IgM. Future research should concentrate on investigating potential differences in 409 
these biomarkers with a particular focus on immune biomarkers and function between dietary 410 
groups given the encouraging, but limited findings of this review which included; lowered 411 
total leukocyte and lymphocyte (in 2/4 studies) concentrations in addition to improved NK 412 
cell activity in 1/2 studies in vegetarian-based groups. Interestingly, of the 2/4 studies which 413 
reported lowered total lymphocyte concentrations in vegetarian-based groups, both 414 
lymphocyte counts were within normal reference ranges (Haddad et al (54), 3.04 ± 0.83 x 415 
109/L,  normal reference range 1.170 – 4.698 x 109/L,(108) and Tungtrongchitr (69) et al; 416 
30% and 33% WBC (medians), normal reference range 18–54% (108)). If lymphocyte counts 417 
are reduced in vegetarian-based populations, yet NK cell cytotoxic activity is improved, the 418 
overall effect on immune function may be favorable. Further exploration into lymphocyte 419 
concentrations and NK cell activity in vegetarian-based populations is required. 420 
While our review was comprehensive and systematic in nature, some limitations must be 421 
noted. Our analysis was limited by the small number of studies assessing the effect of 422 
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vegetarian-based dietary patterns on fibrinogen (n=3) and thrombocytes (n=7) in 423 
observational studies and CRP (n=5) in intervention studies. Furthermore, cross-sectional 424 
studies provide a high risk of bias and lower levels of study quality (compared to RCT’s) 425 
(37). However, inclusion of cross-sectional studies was warranted in this review to provide an 426 
estimation of vegetarian-based eating patterns and their relationship with a wide range of 427 
outcomes across a large population sample. In the case of this review, many studies used unit 428 
reporting methods which could not be converted to a common unit preventing their use in the 429 
meta-analysis, had limited sample sizes and often failed to control for risk factors which may 430 
have influenced inflammatory markers (e.g. BMI, physical activity and smoking status) 431 
which may have increased the risk of bias in these studies. Additionally, many of the 432 
observational studies lacked detail on the types and quality of diet in both vegetarian and 433 
non-vegetarian groups which presents challenges when interpreting the results of these 434 
studies. As mentioned, there was substantial variation between population groups and a small 435 
population sample pool in the intervention study quantitative analysis limiting the 436 
generalisability of the results. Furthermore, it was unclear if three of the intervention studies 437 
were randomized or not. 438 
There are also several strengths of this review. This meta-analysis is the first, to the authors 439 
knowledge, to systematically and quantitatively assess the relation between vegetarian-based 440 
dietary patterns and biomarkers of inflammation and immune status in both observational and 441 
intervention studies. Previous studies  have investigated the effects of specific nutrients and 442 
foods on markers of low-grade inflammation however nutrients and foods are seldom eaten in 443 
isolation (13, 95). A strength of this review is that dietary patterns were considered as a 444 
whole which considers the complex synergistic and/or antagonistic biochemical interactions, 445 
enhancing the applicability to real-life eating patterns (1).  446 
Conclusion 447 
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This study systematically assessed the evidence including observational and intervention 448 
studies comparing common biomarkers of inflammation and immune status in vegetarian-449 
based and mixed non-vegetarian dietary patterns. Vegetarian-based dietary patterns appeared 450 
to be favorable in all quantitative syntheses; however, results should be interpreted with 451 
caution due to the limited number of studies and substantial variation between studies. Future 452 
research should focus on large scale intervention studies, exploring differences in immune 453 
function between vegetarian-based and non-vegetarian based groups. This is justified given 454 
the increased consumption of ‘non-nutritive’ immune modulating phytochemicals typically 455 
consumed in vegetarian-based dietary patterns. Furthermore, since it appears there are 456 
favorable inflammatory profiles in vegetarian-based populations it is plausible immune 457 
function may also be improved given the inherent link between the two physiological 458 
systems. 459 
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Figures 489 
Fig 1. Flowchart of study selection 490 
Fig 2. Difference in CRP values between participants following vegetarian-based dietary 491 
patterns and non-vegetarian dietary patterns (cross-sectional studies). Diamond indicates 492 
weighted mean difference with 95% confidence intervals. 493 
Fig 3. Difference in fibrinogen values between participants following vegetarian-based 494 
dietary patterns and non-vegetarian dietary patterns (cross-sectional studies). Diamond 495 
indicates weighted mean difference with 95% confidence intervals. 496 
Fig 4. Difference in leukocyte values between participants following vegetarian-based dietary 497 
patterns and non-vegetarian dietary patterns (cross-sectional studies). Diamond indicates 498 
weighted mean difference with 95% confidence intervals. 499 
Fig 5. Difference in thrombocyte values between participants following vegetarian-based 500 
dietary patterns and non-vegetarian dietary patterns (cross-sectional studies). Diamond 501 
indicates weighted mean difference with 95% confidence intervals. 502 
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Table 1. Characteristics of observational studies examining the association of participants following vegetarian-based or non-vegetarian dietary 
patterns and common biomarkers of inflammation and immune function.1 
Study 
Design/Level 
of Evidence 
Population/ 
Gender 
Co-
morbidities 
Country 
Age  
(years; mean or 
range) 
Years on 
vegetarian 
diet 
Biomarker/s 
investigated 
Study 
Quality 
/7 
Matched  
(NS different 
at baseline) 
Difference in biomarker 
(significance = P<0.05) 
Acosta-Navarro et 
al. (42)  
Cross sectional V - 44 Nil Brazil V3 = 45.5 
 
> 4 hs-CRP 5 age  
 
● hs-CRP – NS4 
Navarro et al. 2 
(48) 
 NV - 44   NV = 46.8  Leukocytes  gender ● Leukocytes significantly ↓ 
in V group 
  M     Neutrophils  smoking status ● Neutrophils significantly ↓ 
in V group 
         hx of disease  
Ambroszkiewicz 
et al. (43) 
Cross sectional LOV - 43 Nil Poland 4.5–9.0 > 4.5  CRP 4 age ● CRP - NS 
  NV - 46       BMI  
  M & F         
Chen et al. (45) Cross sectional V - 99  
 
 
Nil Taiwan V = 51.24  
 
> 1  Leukocytes  
 
4 age 
 
● CRP - significantly ↑ in 
NV group 
  NV - 99   NV = 49.38  hs-CRP  BMI  
  M & F         
Chen et al. (44) Cross sectional LOV - 173  Nil Taiwan LOV = 54.00  > 1  hs-CRP 5 BMI ● hs-CRP - NS 
  NV - 190   NV = 49.94  Leukocytes   ● Leukocytes - NS 
  F     Thrombocytes   ● Thrombocytes - NS 
Chuang et al. (46) Matched 
cohort/Cross 
sectional 
V - 686  Nil Taipei & 
Taiwan 
V = 45.2  Long-term CRP 5 age  ● CRP significantly ↑ in NV 
group 
  NV - 3423   O = 45.1    location  
  M & F       sex  
Dong and Scott. 
(47) 
Cross sectional Ve - 13 
 
 
 
 
Nil United 
States of 
America 
M = 57 | F = 40 
 
 
> 1 Leukocytes 1 Nil ● Significance not reported 
  LV - 28   M = 45 | F = 42      
  LOV - 15   M= 43 | F = 35      
  NV - 4   M = 31 | F = 55      
  M & F         
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Famodu et al. (49) Cross sectional Ve - 8 
 
 
 
Nil Nigeria Ve = 47.1  
 
 
Long-term Fibrinogen 3 age  
BMI 
● Fibrinogen significantly ↑ 
in NV group compared to 
LOV & Ve group. 
 
  LOV -28   LOV = 49.0       ● Fibrinogen significantly ↑ 
in LOV group compared to 
Ve group 
  NV - 40   NV = 48.7      
  M & F         
Fontana et al. (50) Matched 
Cohort/Cross 
sectional 
Ve - 21 
 
 
Nil United 
States of 
America 
Ve = 53.1 
 
> 2  hs-CRP 2 age ● CRP significantly ↑ in NV 
group. 
  NV - 21   NV = 53.1      
  M & F         
Fontana et al. (51) Matched 
Cohort/Cross 
sectional 
Ve - 18 
 
 
Nil United 
States of 
America 
54.2 1½ - 10 
(range) 
hs-CRP 2 age 
 
 
● hs-CRP significantly ↑ in 
NV group. 
  NV - 18       sex  
  M & F       SES  
Franco-de-Moraes 
(52) 
Cross sectional Ve - 66 
 
 
Nil Brazil Ve = 49.6 
 
 
> 1  TNF-α 
 
 
3 age 
 
● TNF-α - NS 
 
 
  LOV - 102   LOV = 49.6  CRP  sex ● hs-CRP significantly ↑ in 
NV group 
  NV - 100   NV = 49.1  IL-10   ● IL-10 - NS 
Gorczyca et al. 
(53) 
Cross sectional V = 22 
 
 
Nil Poland V = 4  
 
> 1 IgA 
 
 
3 age  
 
● IgA - NS 
 
 
  NV = 18   NV = 9 (range 2 - 
18) 
 IgM  body weight ● IgM - NS 
  M & F     IgG  height ● IgG - NS 
Haddad et al. (54) Cross sectional Ve - 25 
 
 
Nil United 
States of 
America 
Ve = 36.0 
 
> 1 Leukocytes 
 
3 age 
blood lipid 
concentrations. 
● Leukocytes significantly ↓ 
in Ve group 
 
 
  NV - 20   O = 33.5  Lymphocytes  physical 
activity level 
● Lymphocytes significantly 
↓ in Ve group 
  M & F     Neutrophils   ● Neutrophils - NS 
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       Monocytes   ● Monocytes - NS 
       Eosinophils   ● Eosinophils - NS 
       Basophils   ● Basophils - NS 
       Thrombocytes   ● Thrombocytes significantly 
↓ in Ve group 
       IgA   ● IgA - NS 
       IgG   ● IgG - NS 
       IgM   ● IgM - NS 
       CRP   ● CRP - NS 
       NK cell 
cytotoxic 
activity 
  ● NK cell cytotoxic activity - 
NS 
Krajcovicova-
Kudlackova, & 
Blazicek (55) 
Cross sectional LOV - 133 
 
 
Nil Slovakia LOV = 46.2 
 
>1 hs-CRP 2 age ● hs-CRP significantly ↑ in 
NV group. 
  NV - 137   NV = 47.2      
  M & F         
Malter et al. (56) Cross sectional V = 22 Nil Germany V = 28-50 > 1 Thrombocytes 2 age ● Thrombocytes - NS 
  O = 22     Leucocytes  gender ● Leucocytes - NS 
  M     Lymphocytes   ● Lymphocytes - NS 
       Monocytes   ● Monocytes - NS 
       Basophilic 
granulocytes 
  ● Basophilic granulocytes - 
NS 
       Eosinophilic 
granulocytes 
  ● Eosinophilic granulocytes - 
NS 
       NK cell 
cytotoxic 
activity 
  ● NK cell activity of 
peripheral blood lymphocytes 
significantly ↑ in V group. 
Mezzano et al. 
(57) 
Cross sectional V = 26 Nil Chile V = 39 > 1 Platelet count 3 age 
 
 
● Thrombocytes significantly 
↓ in NV group 
  NV = 26     Fibrinogen  sex ● Fibrinogen significantly ↑ 
in NV group 
  M & F     CRP  SES ● CRP - NS 
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Montalcini et al. 
(58) 
Cross sectional LOV = 26 Nil Italy LOV = 32.6 ≥ 3  IL-2 5 age  ● IL-2 - NS 
 
 
  NV = 26   NV = 30.5  IL-4  BMI ● IL-4 - NS 
  M & F     IL-6  gender ● IL-6 - NS 
       IL-8   ● IL-8 - NS 
       IL-10   ● IL-10 - NS 
       TNFα   ● TNFα - NS 
       IL-1α   ● IL-1α - NS 
       IL-1β   ● Interleukin-β significantly 
↑ in LOV group 
Ou et al. (59) Case 
control/Cross 
sectional 
V = 21 
 
 
Patients on 
dialysis 
therapy for >6 
months. 
Taiwan V = 56.27 
 
≥ 1.5 hs-CRP 2 age 
 
● hs-CRP - NS 
  NV = 42   O = 56.29    sex  
  M & F         
Paalani et al. (60) Cross sectional V - 216 
 
 
Nil United 
States of 
America 
68.8 > 1 CRP 
 
 
 
4 Not reported ● CRP significantly ↑ in NV 
group 
  NV - 289     IL-6    
  M & F     IL-10    
       TNF-α    
Pinto et al. (61) Matched 
Cohort/Cross 
sectional 
Ve - 23 
 
 
Nil United 
Kingdom 
Ve = 49 
 
> 2  Il-6 6 age 
 
 
● IL-6 - NS 
  NV - 24   NV = 54    sex  
  F       BMI  
Pongstaporn et al. 
(62) 
Cross sectional V = 179 Nil Thailand V = 18+ > 1 Leukocytes  2 Nil ● Leukocytes significantly ↓ 
in Ve group 
  NV = 58     Thrombocytes   ● Thrombocytes - NS 
  M & F     Neutrophils   ● Neutrophils - NS 
       Lymphocytes   ● Lymphocytes - NS 
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Refsum et al. (63) Cross sectional V = 78 
 
 
100 CVD (42 
of which DM) 
 
India V = 27–55 Long-term Thrombocytes 3 Nil ● Thrombocytes - NS 
  NV = 126 104 without 
CVD (41 
DM) 
       
  M & F         
Sebekova et al. 
(64) 
Cross sectional LOV = 90 Nil Slovakia LOV = 37.7 
 
> 2 Hs-CRP 
 
2 age ● Hs-CRP - NS 
  NV = 46   O = 37.1  Leukocytes  gender ● Leukocytes - NS 
  M & F       BMI  
Sebekova et al. 
(65) 
Cross sectional Ve = 19 Nil Slovakia Ve = 39.6 Ve = 7.2 
 
CRP 2 age ● CRP - NS 
  LOV = 19   LOV = 36.1 LOV = 8.2     
  NV = 9   NV = 30.5      
  M & F         
Su et al. (66) Cross sectional LOV = 49 Nil Taiwan LOV = 58.6 ± 
6.0 
10.8 hs-CRP 3 age ● hs-CRP - NS 
  NV = 41   O = 57.2 ± 5.4    gender  
  F         
Suwannuruks et 
al. (67) 
Cross sectional LOV = 50 Nil Thailand LOV 18-50 >1 Fibrinogen 1 Nil ● Fibrinogen - NS 
  NV = 30     Leukocytes   ● Leukocytes - NS 
  M & F     Thrombocytes   ● Thrombocytes - NS 
Szeto et al. (68) Cross sectional LOV = 30 
 
 
Nil Hong 
Kong 
LOV = 44.2 
 
5-55 (range) hs-CRP 2 age 
 
● CRP significantly ↑ in NV 
group 
  NV = 30   NV = 44.0    sex  
  M & F         
Tungtrongchitr et 
al. (69) 
Cross-sectional LV = 132 Nil Thailand LV 
M = 35.5 | F = 33 
>1 Leukocytes  2 age  ● Leukocytes - NS 
  NV = 47   NV 
M = 32.5| F = 32 
 Neutrophils  sex ● Neutrophils - NS 
  M & F   Median  Lymphocytes  SES ● Lymphocytes significantly 
↓ in LV group 
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       Monocytes  ethnic origin ● Monocytes - NS 
       Eosinophil   ● Eosinophils significantly ↓ 
in female LV group 
compared to male LV and 
NV group. 
       Basophil   ● Eosinophils significantly ↑ 
in male LV group compared 
to female LV group and NV 
group 
       Thrombocytes   ● Basophils - NS 
          ● Thrombocytes - NS 
Wu et al. (70) Cross sectional V = 19 Patients 
receiving 
dialysis 
therapy > 
6 months 
Taiwan V = 63.3 
 
Long before 
HD - Note 
mean length 
of HD = 5.9  
hs-CRP 4 age ● hs-CRP significantly ↑ in 
NV group 
  NV = 299   NV = 57.5  Leukocytes  sex ● Leukocytes significantly ↓ 
in V group 
  M & F       mean HD 
length 
 
Yang et al. (71) Matched 
cohort/Cross 
sectional 
V = 171  
 
 
Nil China V = 32.6  
 
> 1  CRP 4 age ● CRP - NS 
  NV = 12   NV = 34.2      
  M         
 
1 CVD, Cardiovascular Disease; DM, Diabetes Mellitus; HD, Haemodialysis; LOV, Lacto-ovo-vegetarian; LV, Lacto-vegetarian; NR, Not Reported; NS, Not Significant; NV, Non-vegetarian; SES, Socio-Economic-
Status; Ve, Vegan. 
2 Two separate papers identified reporting on same study participants, with different outcome marker/s – Slight difference in Navaro et al’s population; V – 43, NV – 41, age; V = 45.0, NV = 46.5 and study quality; = 4 
between studies. 
3 V, Participants followed a combination of Ve and/or LV and/or LOV. 
4 NS, Not significant = P > 0.05
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Table 2. Overview of included studies reporting on biomarkers and significant differences 
between participants following vegetarian-based or non-vegetarian dietary patterns in 
observational studies.1 
Biomarker 
Studies 
Included 
Differences between groups 
(significance = P < 0.05) 
Lymphocytes (54, 56, 62, 
69) 
4 ↓ in V group in 2/4 studies | NS 2/4 studies 
Neutrophils (48, 54, 62, 
69) 
4 ↓ in NV group in 1/4 studies | NS 3/4 studies 
 
Basophils (54, 56, 69) 3 NS 3/3 studies 
Monocytes (54, 56, 69) 3 NS 3/3 studies 
Eosinophils3  (54, 56, 69) 3 NS 3/3 studies 
NK cell cytotoxic activity 
(54, 56) 
2  ↑ in V group in 1/2 studies | NS 1/2 studies  
Leukocytes (44, 45, 47, 
48, 54, 56, 62, 64, 67, 69, 
70) 
11  ↓ in V group in 6/11 studies | NS 5/11 studies 
Thrombocytes (44, 54, 56, 
62, 63, 67, 69) 
7 ↓ in V group in 1/7 studies 
↑ in V group in 1/7 studies | NS 5/7 studies 
CRP (42-46, 50-52, 54, 
55, 57, 59, 60, 64-66, 68, 
70, 71) 
19 CRP ↓ in veg group in 9/19 | NS 10/19 studies 
TNF-α4 (52, 58, 60) 3 NS 
Fibrinogen (49, 57, 67) 3 ↑ in NV group in 2/3 studies | NS 1/3 studies 
Interleukins 
 
  
IL-10 (52, 58, 60) 
 
3 
 
NS 
 
IL-6 (58, 60, 61) 3 NS 
IL-2, IL-4, IL-8, IL-1α,IL-
1β (58) 
1 IL-1β ↑ in V group in 1/1 study 
Immunoglobulins 
 
  
IgA, IgM, IgG (53, 54) 2 NS 
1 NV, Non-Vegetarian; V, Vegetarian-based. 
2 NS, not significant between groups (P > 0.05) 
3 Tungtrongchitr et al compared medians between groups and genders. Eosinophils were significantly ↓ in the NV group 
compared to the male LV group but significantly ↑ compared to the female LV group. 
4
 Significance not reported in one study. 
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Table 3. Meta-analysis summary of observational studies comparing CRP, thrombocytes, 
fibrinogen and leukocytes between vegetarian-based and non-vegetarian based dietary 
patterns. 
 
Outcome 
Number of 
analyses 
Number of 
Vegetarian 
participants 
Number of 
control 
participants 
Effect Estimate  
(95% CI) 
P value 
Inconsistency 
(I2) 
GRADE 
Quality 
CRP (mg/L) 18 1844 4736  -0.61 (-0.91, -0.32) 0.001 100% Very Low 
Thrombocytes (x109/L) 7 663 507 8.24 (-3.35, 19.82) 0.16 35% Very Low  
Fibrinogen (g/L) 3 112 96  -0.22 (-0.41, -0.04) 0.02 17%  Very Low 
Leukocytes (103/μL) 11 944 970  -0.62 (-1.13, -0.10) 0.02 96%  Very Low 
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Table 4. Characteristics of interventional studies examining the effect of vegetarian dietary patterns and non-vegetarian dietary patterns on 
common biomarkers of inflammation and immune function1 
Study/Year 
Study 
design/Level of 
Evidence 
Population/ 
Gender 
Comorbidities Country 
Age in 
years 
(mean or 
range) 
Duration of 
vegetarian 
diet (weeks) 
Intervention  
Vegetarian 
dietary pattern 
Control 
Non-
Vegetarian 
Biomarker/s 
investigated 
Matched  
(baseline 
participant 
characteristics 
matched) 
Difference in 
biomarker 
(significance 
= p<0.05) 
Elkan et al. 
(72) 
RCT (Level II)2 Ve = 30 
 
 
Patients with RA 
(2 and 10 years 
duration) 
Sweden Ve = 49.9  
 
52 Ve  
 
 
Well-balanced 
mixed diet from 
5 food groups 
 
CRP Age 
 
 
 
 
hs-CRP 
significantly 
↓ within LV 
group 
  NV = 28   NV = 50.8  Gluten Free (CHO 55% to 
60%,10%-15% 
Pro, Fat < 30% 
with < 10% 
saturated). 
 Weight  
  M & F     (CHO 60%, Pro 
10%, Fat 30%) 
  BMI    
          Disease 
duration 
 
          Concomitant 
treatment 
 
Hunt & 
Roughead 
(81) 
RCT (Level II; 
crossover) 
n = 21  
 
Nil U.S.A 33.2 8 (nil 
washout) 
LOV  LOV with 
~184g meat (3 
parts beef and 
1-part 
chicken)/d 
CRP N/A  - 
Crossover 
CRP – NS 
  F     ↑ amounts of 
legumes, 
wholegrains, 
breads/cereals 
fruits and 
vegetables 
    
       Cessation of 
supplements 
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Kahleova et 
al. (73) 
RCT (Level II) LV = 37 
 
 
Patients with 
T2DM 
Czech 
Republic 
LV = 54.6  
 
12 LV 
 
 
Conventional 
T2DM diet as 
per DNSG of 
the EASD 
 
hs-CRP 
 
Significant 
differences 
between 
groups not 
reported at 
baseline 
hs-CRP 
significantly 
↓ in LV 
group 
 
  NV = 37   NV = 57.7  Animal products 
were limited to 
one low-fat 
yogurt a day. 
(50% CHO, 
20% Pro, < 
30% fat; ≤ 7% 
saturated fat, < 
200 mg⁄ day of 
cholesterol). 
Fibrinogen  Fibrinogen – 
NS 
  M & F     (60% CHO, 15% 
Pro & 25% fat) 
    
Kjeldsen-
Kragh et al3. 
(74, 75)  
RCT (Level II) Ve = 27 Classic or 
definite RA 
Norway Ve = 53  56 Ve Habitual mixed 
diet 
CRP Significant 
differences 
between 
groups not 
reported at 
baseline 
hs-CRP 
significantly 
↓ in Ve group 
  NV = 26   NV = 56  Gluten free Ve 
for 3.5 months.  
Followed by 
LOV for 9.5 
months 
 Thrombocyte
s 
 Thrombocyte
s 
significantly 
↓ in Ve group 
  M & F       Leukocytes  leukocytes 
significantly 
↓ in Ve group 
         TNFα  TNFα - NS 
         IgM  IgM 
significantly 
↓ in Ve group 
         IgA  IgA - NS 
         IgG  IgG 
significantly 
↓ Ve group 
(after 1 
month 
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Macknin et 
al. (76) 
RCT (Level II) Ve = 14 Children 
BMI > 95th % 
for age/sex, 
cholesterol 
>169mg/dl 
U.S.A Children  
Ve = 15.0 
O = 15.0 
4 Ve American Heart 
Association diet 
hs-CRP No significant 
difference in 
biomarkers at 
baseline 
hs-CRP 
significantly 
↓ in children 
on Ve 
  NV = 14   Adults 
Ve = 46.5  
O = 46.0 
 avoidance of 
added fat and 
limited intake of 
nuts and 
avocado. 
(Fat total 30% , 
7%  saturated 
fat, < 300 mg of 
cholesterol, < 
1500 mg of 
sodium daily) 
IL-6  IL-6 – NS 
  Overweight 
children with 1 x 
accompanying 
parent 
         
  M & F          
Nenonen et 
al. (77) 
RCT (Level II) Ve = 22 Chronic and 
active RA 
Finland Ve = 49.1 12 Ve Habitual mixed 
diet 
CRP Height CRP – NS 
  NV = 21 CRP >10 mg/l  NV = 55.6  Rich in 
lactobacilli 
  Weight  
  M & F        BMI  
          Duration of 
RA 
 
          Seropositivity  
          Medication  
Richter et al. 
(78) 
 Non-
randomized 
crossover design 
(Level III-2)4 
n = 8  Nil Denmark 21-28 12 (2 x 6 
(crossover; 4 
weeks 
washout) 
LOV  High amounts 
of animal 
protein  
(CHO 57%, Pro 
14%, Lipids 
29%) 
Monocytes 
conc 
N/A - 
Crossover 
Monocytes - 
NS 
  well-trained 
male athletes 
    High in 
vegetable protein 
sources 
 Monocytes 
(CD14+) 
 Monocytes 
(CD14+) - 
NS 
34 
 
  M     (CHO 57%, Pro 
14%, Lipids 
29%) 
 NK cells 
(CD16+) 
 NK cells 
(CD16+) - 
NS 
         Pan T cells 
(CD3+) 
 Pan T cells 
(CD3+) - NS 
         T suppressor 
cells (CD8+) 
 T suppressor 
cells (CD8+) 
- NS 
         T Helper 
cells (CD4+) 
 T Helper 
cells (CD4+) 
– NS 
Sköldstam et 
al. (80) 
RCT (Level II) LOV = 15 Classical RA Sweden LOV = 
35-56 
12 LOV  Habitual mixed 
diet 
Leukocytes Not reported Leukocytes - 
NS 
  NV = 10   NV = 43-
66 
 Nil alcohol, 
tobacco, coffee/ 
tea. Limited salt, 
sugar, white 
flour and grain 
products. 
 T 
lymphocytes 
 T 
lymphocytes 
- NS 
  M & F       B 
lymphocytes 
 B 
lymphocytes 
- NS 
         IgG  IgG - NS 
         IgA  IgA - NS 
         IgM  IgM 
significantly 
↑ within LOV 
group 
Sköldstam 
(79) 
Non-
randomized 
crossover design 
(Level III-2) 
n = 20 
 
Classical or 
definite RA 
Sweden 35-68 16 Ve Habitual mixed 
diet 
CRP N/A - 
Crossover 
CRP – NS 
  NR          
1 CHO, Carbohydrates; F, Female; LOV, Lacto-ovo-vegetarian; LV, Lacto-vegetarian; M, Male; NR, Not Reported; NS, Not Significant (P > 0.05); NV, Non-vegetarian; 
Pro, Protein; RA, Rheumatoid Arthritis; T2DM, Type 2 Diabetes Mellitus; Ve, Vegan. 
2 RCT (Level II), Randomized Controlled Trial.  
3 Same study/participants - Different outcomes investigated. 
4 (Level III-2), A comparative study with concurrent controls: Non-randomized, experimental trial. 
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Table 5. Overview of included studies reporting on biomarkers and significant differences 
between vegetarian and non-vegetarian based dietary patterns in intervention studies1 
Biomarker 
Studies 
Included 
Differences between groups (significance = P <0.05) 
Lymphocytes(80) 1 
NS 
Monocytes(78) 1 
NS 
Monocytes (CD14+)(78) 1 
NS 
Pan T cells (CD3+)(78) 1 
NS 
T Suppressor cells 
(CD8+)(78) 
1 
NS 
T Helper cells (CD4+)(78) 1 
NS 
NK cells(78) 1 
NS 
Leukocytes(74, 80)  2 
↓ in V group in 1/2 studies | NS 1/2 studies 
Thrombocytes(74) 1 
↓ in V group in 1/1 studies 
CRP(72-74, 76, 77, 79, 81) 7 
↓ in V group in 4/7 | NS 3/7 studies 
TNF-α(75) 1 
NS 
Fibrinogen(73)  1 
NS 
Interleukins 
 
 
IL-6(76) 1 
 NS 
Immunoglobulins 
 
 
IgM(75, 80) 
IgA(75, 80) 
IgG(75, 80) 
  
2 
2 
2 
↓ in V group in 1/2 studies | ↑ within V group in 1/2 
studies 
NS 
↓ in V group in 1/2 studies | NS 1/2 studies 
1 NS, not significant (P > 0.05); V, Vegetarian-based.  
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Supplemental Table 1: Example of the search strategy 
 (((((((((((((((((((((((((((((((((((((("immunoglobulins"[MeSH Terms]) OR Immunoglobulin*) 
OR IgE) OR IgD) OR IgM) OR IgA) OR IgG) OR Platelet[MeSH Terms]) OR Platelet*) OR 
Basophil[MeSH Terms]) OR Basophil*) OR Eosinophil[MeSH Terms]) OR Eosinophil*) OR 
"t lymphocyte subsets"[MeSH Terms]) OR t cell*) OR "b lymphocyte subsets"[MeSH 
Terms]) OR B cell*) OR Monocyte[MeSH Terms]) OR Monocyte*) OR Neutrophil[MeSH 
Terms]) OR Neutrophil*) OR Leukocyte[MeSH Terms]) OR Lymphocyte*) OR 
Lymphocyte*[MeSH Terms]) OR Leukocyte*) OR white blood cells) OR "white blood 
cells") OR white blood cell) OR "white blood cell") OR NK) OR "natural killer t 
cells"[MeSH Terms]) OR "natural killer cells") OR natural killer cells) OR natural killer cell) 
OR "natural killer cell") OR "immunity"[MeSH Terms]) OR immune)) OR (((tumor necrosis 
factor[MeSH Terms]) OR interleukin[MeSH Terms]) OR (((((((((((((((((("fibrinogen"[MeSH 
Terms]) OR fibrinogen) OR TNF) OR "tumor necrosis factor alpha"[MeSH Terms]) OR 
tumour necrosis factor) OR "tumour necrosis factor") OR "tumor necrosis factor") OR IL-6) 
OR interleukin) OR "interleukin") OR CRP) OR "c reactive protein") OR C-Reactive 
Protein[MeSH Terms]) OR inflammat*) OR "inflammation"[MeSH Terms])))) AND 
((((((("plant based") OR "plant-based") OR vegan*) OR "vegans"[MeSH Terms]) OR 
*vegetarian) OR vegetarian*) OR vegetarian[MeSH Terms])   
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies  
 
Acosta-
Navarro et al 
(42), 
Navarro et 
al. (48) 1 
Justification  
Ambroszkiewicz 
et al. (43) 
Justification Chen et al. (45) Justification Chen et al. (44) Justification 
Chuang et 
al. (46) 
Justification 
Dong 
and 
Scott 
(47) 
Justification 
Sample selection criteria 
Selection: (Maximum 3 stars) 
            
1) Representativeness of the 
sample: 
a) Truly representative of the 
average in the target population. ★ 
(all subjects or random sampling) 
b) Somewhat representative of the 
average in the target population. ★ 
(non-random sampling) 
c) Selected group of users. 
d) No description of the sampling 
strategy. 
1b ★ 
small 
sample size 
1b ★ 
children 
aged 4.5-9 
1b ★ 
All pts 
undergoing 
general 
health 
examination, 
but enrolled 
first come, 
first served 
1b ★ females only 1b  ★ 
large sample 
based on health 
records of pts in 
clinics, but not 
clear how 
vegetarian and 
non-vegetarian 
cases/controls 
were identified 
1c 
pts of a 
vegetarian 
society 
conference 
+ very 
small non-
veg group 
2) Non-respondents: 
a) Comparability between 
respondents and non-respondents 
characteristics is established, and 
the response rate is satisfactory. ★ 
b) The response rate is 
unsatisfactory, or the 
comparability between 
respondents and non-respondents 
is unsatisfactory. 
c) No description of the response 
rate or the characteristics of the 
responders and the non-
responders. 
2a ★  - 2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c no description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
3) Ascertainment of the exposure 
(risk factor): 
a) Validated measurement tool. ★ 
b) Non-validated measurement 
tool, but the tool is available or 
described.  
c) No description of the 
measurement tool. 
NOTE - Study must say 'validated' 
to score star  
 
 
 
 
 
3b  - 3b 
tool 
described, 
but not 
clear if 
validated 
3c 
No 
description - 
general diet 
only 
3c 
No 
description 
of 
questionnaire 
used 
3a ★ validated tool 3b  
tool 
described, 
but not 
clear if 
validated 
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
Comparability: (Maximum 2 
stars) 
1) The subjects in different 
outcome groups are comparable, 
based on the study design or 
analysis. Confounding factors are 
controlled. 
a) The study controls for the most 
important factor (BMI). ★ 
b) The study controls for any 
additional factors. ★ (Smoking 
and physical activity) 
Note: for ★ on 1b - both PA and 
smoking needs to be controlled 
1b ★ 
ANOVA 
analysis 
performed 
due to 
differences 
in PA 
1a ★ 
PA not 
considered 
BMI 
similar 
between 
groups, 
other 
factors not 
discussed 
1a ★ 
Sig. 
differences 
in smoking 
1a ★ 
1b ★ 
Did not 
statistically 
adjust, but 
exclusion 
criteria 
would have 
limited 
confounders 
somewhat 
1b ★ 
Did not adjust 
for BMI 
(differed 
significantly 
between 
groups), but did 
adjust for age, 
sex, PA, 
alcohol and 
study site 
- 
Does not 
appear to 
adjust for 
confounders 
Outcome: (Maximum 2 stars)                         
1) Assessment of the outcome: 
a) Independent blind assessment. 
★ 
b) Record linkage. ★ 
c) Self report.   
 d) No description. 
2) Statistical test: 
a) The statistical test used to 
analyse the data is clearly 
described and appropriate, and the  
measurement of the association is 
presented, including confidence 
intervals and the probability level 
(p value). ★ 
b) The statistical test is not 
appropriate, not described or 
incomplete. 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a   ★ 
2a   ★ 
 - 
1a   ★ 
2a   ★ 
 - 
1a   ★ 
2a   ★ 
 - 
1a  ★ 
2b 
- 
Total ★ ( /7) 2 5   4   4   5   5   1   
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
 
Famodu 
et al. 
(49) 
Justification 
Fontana 
et al. 
(50) 
Justification 
Fontana 
et al. 
(51) 
Justification 
Franco-
de-
Moraes 
et al. 
(52)  
Justification 
Gorczyca 
et al. (53)  
Justification 
Haddad 
et al. 
(54) 
Justification 
Sample selection criteria  
Selection: (Maximum 3 stars) 
            
1) Representativeness of the sample: 
a) Truly representative of the average 
in the target population. ★ (all 
subjects or random sampling) 
b) Somewhat representative of the 
average in the target population. ★ 
(non-random sampling) 
c) Selected group of users. 
d) No description of the sampling 
strategy. 
1d 
no description of 
sampling 
strategy (states 
members of 
Adventist 
Seminary 
Institute of West 
Africa.) + non-
vegetarians 
1c 
small select 
sample, not 
representative 
raw vegans 
1c 
small sample, 
not clear how 
controls 
recruited, not 
representative 
1b  ★ 
convenience 
sample 
1c 
parents of non-
vegetarian 
children not 
randomly 
selected 
1c 
small sample, 
unlikely to be 
representative 
2) Non-respondents: 
a) Comparability between 
respondents and non-respondents 
characteristics is established, and the 
response rate is satisfactory. ★ 
b) The response rate is unsatisfactory, 
or the comparability between 
respondents and non-respondents is 
unsatisfactory. 
c) No description of the response rate 
or the characteristics of the 
responders and the non-responders. 
2c 
no description of 
those not 
enrolled 
2c 
no description of 
those not 
enrolled 
2c 
no description of 
those not 
enrolled 
2c 
no 
description of 
those not 
enrolled 
2c 
no description 
of those not 
enrolled 
2c 
no description of 
those not enrolled 
3) Ascertainment of the exposure (risk 
factor): 
a) Validated measurement tool. ★ 
b) Non-validated measurement tool, 
but the tool is available or described.  
c) No description of the measurement 
tool. 
NOTE - Study must say 'validated' to 
score star 
3b  
tool described in 
supporting 
reference, but 
not described if 
validated 
3b  
WFR - but no 
mention of 
validating 
3b 
WFR but no 
mention of 
validation 
3c  - 3b 
FR used but 
unsure if 
validated 
3b  
FR (trained) but no 
mention of validation 
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome 
groups are comparable, based on the 
study design or analysis. 
Confounding factors are controlled. 
a) The study controls for the most 
important factor (BMI). ★ 
b) The study controls for any 
additional factors. ★ (Smoking and 
physical activity) 
Note: for ★ on 1b - both PA and 
smoking needs to be controlled 
1a  ★ 
did not adjust for 
confounders, 
although no 
difference in 
BMI. 
 
No description of 
smoking status 
or PA 
- 
Did not adjust 
for confounders 
(differences in 
BMI) 
 
smoking same 
between groups 
however no 
description of 
PA between Ve 
and NV 
- 
Did not adjust 
for confounders 
(differences in 
BMI) 
 
smoking same 
between groups 
however no 
description of 
PA between Ve 
and NV 
Nil 
BMI and PA 
not controlled 
1a  ★ 
did not adjust 
for 
confounders, 
or control for 
PA or 
smoking. 
 
Height and 
weight not sig 
different 
between 
groups 
1b  ★ 
BMI sig diff between 
groups. 
 
PA and Smoking no 
sig diff 
Outcome: (Maximum 2 stars)                         
1) Assessment of the outcome: 
a) Independent blind assessment. ★ 
b) Record linkage. ★ 
c) Self report.   
 d) No description. 
2) Statistical test: 
a) The statistical test used to analyse 
the data is clearly described and 
appropriate, and the  
measurement of the association is 
presented, including confidence 
intervals and the probability level (p 
value). ★ 
b) The statistical test is not 
appropriate, not described or 
incomplete. 
1a   ★ 
2a   ★ 
-  
1a   ★ 
2a   ★ 
 - 
1a   ★ 
2a   ★ 
-  
1a   ★ 
2a   ★ 
 - 
1a   ★ 
2a   ★ 
-  
1a   ★ 
2a   ★ 
 - 
Total ★ ( /7) 3   2   2   3   3   3   
 
 
 
 
 
Supplementary Data 
47 
 
Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
 
Krajcovicova-
Kudlackova 
et al. (55) 
Justification 
Malter et 
al. (56) 
Justification 
Mezzano et 
al. (57) 
Justification 
Montalcini 
et al. (58) 
Justification 
Ou et al. 
(59) 
Justification 
Paalani et 
al. (60) 
Justification 
Sample selection criteria 
Selection: (Maximum 3 stars) 
            
1) Representativeness of the sample: 
a) Truly representative of the average in the 
target population. ★ (all subjects or random 
sampling) 
b) Somewhat representative of the average in 
the target population. ★ (non-random 
sampling) 
c) Selected group of users. 
d) No description of the sampling strategy. 
1b ★  
random 
sampling 
but no 
description 
of strategy 
1c 
small 
sample, not 
clear how 
selected 
from 
Heidelberg 
study (veg) 
or research 
centre (non-
veg) 
1d 
not 
described 
1b ★ 
small 
sample, but 
recruited 
following 
newspaper 
ads 
1c 
chronic 
dialysis 
patients 
1a ★ -  
2) Non-respondents: 
a) Comparability between respondents and non-
respondents characteristics is established, and 
the response rate is satisfactory. ★ 
b) The response rate is unsatisfactory, or the 
comparability between respondents and non-
respondents is unsatisfactory. 
c) No description of the response rate or the 
characteristics of the responders and the non-
responders. 
2c 
No 
description 
of those not 
enrolled 
2c 
No 
description 
of those not 
enrolled 
2c 
No 
description 
of those not 
enrolled 
2c 
No 
description 
of those not 
enrolled 
2c 
No 
description 
of those not 
enrolled 
2a ★ -  
3) Ascertainment of the exposure (risk factor): 
a) Validated measurement tool. ★ 
b) Non-validated measurement tool, but the tool 
is available or described.  
c) No description of the measurement tool. 
NOTE - Study must say 'validated' to score star  
3c 
tool not 
described 
3c no tool 3b  
tool 
described, 
but not 
clear if 
validated 
3b 
tool 
described, 
but not 
clear if 
validated 
3c 
tool not 
described 
3b 
tool 
described, 
unclear if 
validated 
Comparability: (Maximum 2 stars)                         
1) The subjects in different outcome groups are 
comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important 
factor (BMI). ★ 
b) The study controls for any additional factors. 
★ (Smoking and physical activity) 
Note: for ★ on 1b - both PA and smoking needs 
to be controlled 
- 
smoking 
controlled 
for, 
however 
BMI sig 
difference 
and no 
description 
of PA 
- 
did not 
adjust for 
confounders 
(differences 
in other risk 
factors 
between 
groups) 
1a  ★ 
matched by 
BMI, age, 
sex - no 
mention of 
PA 
1a  ★ 
matched by 
BMI, age, 
sex. PA sig 
different 
between 
groups 
- 
age and sex 
matched, 
but BMI 
still sig 
different 
between 
groups, and 
not adjusted 
- 
Baseline 
data not 
available  
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
Outcome: (Maximum 2 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment. ★ 
b) Record linkage. ★ 
c) Self report.   
 d) No description. 
2) Statistical test: 
a) The statistical test used to analyse the data is 
clearly described and appropriate, and the  
measurement of the association is presented, 
including confidence intervals and the 
probability level (p value). ★ 
b) The statistical test is not appropriate, not 
described or incomplete. 
1a   ★ 
2b 
-  
1a   ★ 
2a   ★ 
-  
1a   ★ 
2a   ★ 
 - 
1a   ★ 
2a   ★ 
-  
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
-  
Total ★ ( /7) 2   2   3   4   2   4   
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
 
Pinto et al. 
(61) 
Justification  
Pongstaporn 
et al. (62) 
Justification 
Refsum et 
al. (63) 
Justification 
Sebekova 
et al. (64) 
Justification 
Sebekova 
et al. (65) 
Justification 
Su et al. 
(66) 
Justification 
Sample selection criteria 
Selection: (Maximum 3 stars) 
            
1) Representativeness of the sample: 
a) Truly representative of the average in the target 
population. ★ (all subjects or random sampling) 
b) Somewhat representative of the average in the 
target population. ★ (non-random sampling) 
c) Selected group of users. 
d) No description of the sampling strategy. 
1b ★ 
recruited 
via email, 
adverts and 
email 
circulation 
1d  - 1b ★ 
large 
numbers but 
obtained 
from cardiac 
clinic 
1d -  1d  - 1c 
small select 
sample 
2) Non-respondents: 
a) Comparability between respondents and non-
respondents characteristics is established, and the 
response rate is satisfactory. ★ 
b) The response rate is unsatisfactory, or the 
comparability between respondents and non-
respondents is unsatisfactory. 
c) No description of the response rate or the 
characteristics of the responders and the non-
responders. 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
3) Ascertainment of the exposure (risk factor): 
a) Validated measurement tool. ★ 
b) Non-validated measurement tool, but the tool is 
available or described.  
c) No description of the measurement tool. 
NOTE - Study must say 'validated' to score star 
3a ★ 
validated 
FFQ 
3c 
tool not 
described 
3b  
tool 
described, 
but not clear 
if validated 
3b  
tool 
described, 
but not 
clear if 
validated 
3b  
tool 
described, 
but not 
clear if 
validated 
3c 
tool not 
described 
Comparability: (Maximum 2 stars)   
                   
1) The subjects in different outcome groups are 
comparable, based on the study design or analysis. 
Confounding factors are controlled. 
a) The study controls for the most important factor 
(BMI). ★ 
b) The study controls for any additional factors. ★ 
(Smoking and physical activity) 
Note: for ★ on 1b - both PA and smoking needs to be 
controlled 
1a ★ 
BMI 
controlled - 
Nil for PA  
-  - - 
does not 
control for 
confounders, 
unclear if 
potential 
confounders 
differed 
between 
groups 
- 
BMI sig 
different. 
Smoking 
controlled 
but not PA 
- 
does not 
control for 
confounders 
1a ★ 
BMI not sig 
diff 
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
Outcome: (Maximum 2 stars) 
 
1) Assessment of the outcome: 
a) Independent blind assessment. ★ 
b) Record linkage. ★ 
c) Self report.   
 d) No description. 
2) Statistical test: 
a) The statistical test used to analyse the data is 
clearly described and appropriate, and the  
measurement of the association is presented, 
including confidence intervals and the probability 
level (p value). ★ 
b) The statistical test is not appropriate, not described 
or incomplete. 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
-  
Total ★ ( /7) 5   2   3   2   2   3   
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
 
Suwannuruks 
et al. (67) 
Justification Szeto et al. (68) Justification 
Tungtrongchitr 
et al. (69) 
Justification Wu et al. (70) Justification Yang et al. (71) Justification 
Sample selection criteria 
Selection: (Maximum 3 stars) 
          
1) Representativeness of the sample: 
a) Truly representative of the average in the target 
population. ★ (all subjects or random sampling) 
b) Somewhat representative of the average in the 
target population. ★ (non-random sampling) 
c) Selected group of users. 
d) No description of the sampling strategy. 
1c 
small select 
sample 
1c 
small select 
sample 
1c 
small select 
sample, not 
clear how 
controls 
recruited 
1b ★ 
patients on 
HD 
1c 
select sample, 
not 
representative 
2) Non-respondents: 
a) Comparability between respondents and non-
respondents characteristics is established, and the 
response rate is satisfactory. ★ 
b) The response rate is unsatisfactory, or the 
comparability between respondents and non-
respondents is unsatisfactory. 
c) No description of the response rate or the 
characteristics of the responders and the non-
responders. 
2c 
no 
description 
of those not 
enrolled 
2c 
no 
description 
of those not 
enrolled 
2c 
no description 
of those not 
enrolled 
2a ★  - 2c 
no description 
of those not 
enrolled 
3) Ascertainment of the exposure (risk factor): 
a) Validated measurement tool. ★ 
b) Non-validated measurement tool, but the tool is 
available or described.  
c) No description of the measurement tool. 
NOTE - Study must say 'validated' to score star 
3c 
tool not 
described 
3c 
tool not 
described 
3c 
tool not 
described 
3b  
tool 
described, 
but not clear 
if validated 
3b  
tool described, 
but not clear if 
validated 
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Supplemental Table 2. Modified Newcastle Ottawa Scale assessing of the quality of studies - Continued 
Comparability: (Maximum 2 stars) 
 
1) The subjects in different outcome groups are 
comparable, based on the study design or analysis. 
Confounding factors are controlled. 
a) The study controls for the most important factor 
(BMI). ★ 
b) The study controls for any additional factors. ★ 
(Smoking and physical activity) 
Note: for ★ on 1b - both PA and smoking needs to be 
controlled 
- 
not adjusted 
for 
confounders 
-  - - -  - 
some 
differences 
between groups, 
did not adjust 
1a  ★ 
2a  ★ 
Table 1 
footnotes 
suggest adjusted 
for covariates 
Outcome: (Maximum 2 stars)                     
1) Assessment of the outcome: 
a) Independent blind assessment. ★ 
b) Record linkage. ★ 
c) Self report.   
 d) No description. 
2) Statistical test: 
a) The statistical test used to analyse the data is 
clearly described and appropriate, and the  
measurement of the association is presented, 
including confidence intervals and the probability 
level (p value). ★ 
b) The statistical test is not appropriate, not described 
or incomplete. 
1a  ★ 
2b 
stats test not 
described 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
 - 
1a  ★ 
2a  ★ 
-  
★Total = /7 1   2   2   4   4   
BMI, body mass index; diff, difference; FFQ, food frequency questionnaire; FR, food record; HD, hemodialysis; NV, Non-vegetarian; PA, physical activity; Pts, patients; sig, significant; ve, 
vegan; veg, vegetarian; WFR, weighted food record. 
1 Two separate papers identified reporting on same study participants, with different outcome marker/s  
2 Studies assessed using the modified Newcastle Ottawa Scale can achieve 7 stars in total. Studies attracting 7 stars are of high quality while studies attracting 0 stars are of low quality. The 
criteria in the first column explains the criteria to attain a star. 
★, Sample selection criteria met  
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Supplemental Table 3: GRADE assessment of the quality of the body of evidence in observational studies for each outcome  
Quality assessment № of patients Effect 
Quality Importance 
№ of 
studies 
Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations 
Vegetarian-
based 
control 
Relative 
(95% CI) 
Absolute 
(95% CI) 
CRP 
19 Observational 
studies  
serious a serious b not serious  not serious  None 3 1844 4736 -  MD 0.62 
lower 
(0.93 
lower to 
0.30 
lower)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Fibrinogen 
3 Observational 
studies 
serious 1 not serious 4 not serious  serious  none 3 112 96  -  MD 0.22 
lower 
(0.41 
lower to 
0.04 
lower)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Thrombocytes 
7 Observational 
studies 
serious 1 not serious 4  not serious not serious  none  663  507  -  MD 8.24 
higher 
(3.35 
lower to 
19.82 
higher)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Leukocytes 
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Quality assessment № of patients Effect 
Quality Importance 
№ of 
studies 
Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations 
Vegetarian-
based 
control 
Relative 
(95% CI) 
Absolute 
(95% CI) 
11 Observational 
studies 
serious 1 serious 2 not serious 3  not serious  none  944 970 -  MD 0.62 
lower 
(1.13 
lower to 
0.10 
lower)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
CI, Confidence interval; MD, Mean difference 
1 The studies were viewed as being in the category of 'serious limitation'. This category was selected as the risk of bias assessments for each study using a modified Newcastle Ottawa Scale resulted in many studies scoring poorly (majority 4 
or less /7). In accordance with the GRADE guidelines, 'high risk' needed to be categorized as either 'serious limitations' or 'very serious limitations'. In view of the potential implications of the 'high risk' aspects on the quality of the body of 
evidence, 'serious limitations' was selected.  
2 I squared value of 100%, indicating considerable heterogeneity  
3 Funnel plot does not indicate publication bias  
4 I squared value of <50% indicating minimal heterogeneity  
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Supplemental Figure 1A. Bias assessment plot for leukocyte concentration with Egger’s test 
applied. Egger bias 4.439487; 95% CI: -0.439381, 9.318356; P = 0.0697 
 
 
 
Supplemental Figure 1B. Bias assessment plot for CRP concentration with Egger’s test 
applied. Egger bias: -5.165008; 95% CI: -13.583609, 3.253593; P = 0.2118 
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Supplemental figure 2A. Sensitivity analysis for leukocyte (103/μL) values between those 
following vegetarian-based dietary patterns and non-vegetarian dietary patterns (cross-
sectional studies) with Pongstaporn et al omitted. Diamond indicates weighted mean 
difference with 95% confidence intervals. 
 
 
Supplemental figure 2B. Sensitivity analysis for thrombocyte (x109/L) counts between those 
following vegetarian-based dietary patterns and non-vegetarian dietary patterns (cross-
sectional studies) with Haddad et al omitted. Diamond indicates weighted mean difference 
with 95% confidence intervals. 
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Supplemental figure 3A. Sensitivity analysis for leukocytes (103/μL) between those 
following vegetarian-based and non-vegetarian based dietary patterns (cross-sectional 
studies) with studies omitted where participants were receiving haemodialysis treatment, 
CVD and/or T2DM were omitted. Diamond indicates weighted mean difference with 95% 
confidence intervals. 
 
 
Supplemental figure 3B. Sensitivity analysis for CRP (mg/L) between those following 
vegetarian-based and non-vegetarian based dietary patterns (cross-sectional studies) with 
studies omitted where participants were receiving haemodialysis treatment, CVD and/or 
T2DM were omitted. Diamond indicates weighted mean difference with 95% confidence 
intervals. 
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Supplemental Figure 4A. Difference in CRP (mg/L) values between those following vegan 
dietary patterns and non-vegetarian dietary patterns (cross-sectional studies). Diamond 
indicates weighted mean difference with 95% confidence intervals 
 
 
Supplemental Figure 4B. Difference in CRP (mg/L) values between those following Lacto-
ovo-vegetarian dietary patterns and non-vegetarian dietary patterns (cross-sectional studies). 
Diamond indicates weighted mean difference with 95% confidence interval.
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Quality assessment № of patients Effect 
Qual
ity 
Importan
ce № of 
studi
es 
Study 
design 
Risk 
of 
bias 
Inconsist
ency 
Indirect
ness 
Impreci
sion 
Other 
considerat
ions 
Vegetar
ian Diet 
Mixed 
non-
vegetar
ian diet 
Relat
ive 
(95% 
CI) 
Absol
ute 
(95% 
CI) 
CRP 
4  randomized
trials  
seriou
s  1 
serious 2 serious 3  serious 4  nil 114 116 -  MD 
1.07  
lower 
(2.75 
lower 
to 
0.61 
higher
) 
⨁◯
◯◯ 
VER
Y 
LOW  
IMPORT
ANT 
MD – mean difference,  
1 The studies were viewed as bring in the category of 'serious'. This category was selected as despite risk of bias assessments 
for each study mainly compromising of 'low risk' and 'unclear risk' (see risk of bias assessment charts) the ‘other bias’s domain 
had 100% of studies in the ‘high risk category’. In accordance with the GRADE guidelines, 'high risk' should be downgraded 
by one level when “one criterion or some limitations for multiple criteria, sufficient to lower confidence in the estimate of 
effect” was selected. 
2 Inconsistency was deemed to be ‘not serious’ as the I squared value of 53%, which only slightly exceeded the range (50%-
75%) which “likely indicates substantial heterogeneity” as outlined in the Cochrane handbook.   
3 The studies were viewed as bring in the category of 'serious'. This category was selected, as there was considerable 
inconsistency between the populations regarding the main review question. For example, Elkan et als, 2008 study examined 
participants with rheumatoid arthritis, Kahleova et al, had patients had T2DM and Macknin et al, 2015 had participants who 
were children with a BMI > 95th % for age/sex + cholesterol >169mg/dL. 
4 95% CI does not include an effect, 95% CI does not include appreciable benefit or harm, however less than 400 participants 
available, therefore the decision was made to downgrade the quality of evidence. 
 
Supplemental Figure 5. GRADE assessment of the quality of the body of evidence – CRP 
intervention studies 
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Supplemental Figure 6. Change in C-reactive protein (mg/L) between vegetarian dietary 
patterns and non-vegetarian control dietary patterns (presented as sub-groups based on mean 
final or change values for readability). Diamond indicates weighted mean difference with 
95% confidence intervals. 
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Supplemental Table 4. Cochrane risk of bias assessment of interventional studies 
Elkan et al. (72) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear risk 
"Participants were randomly assigned using a minimization technique" - no 
specific detail on how this was performed. 
Allocation concealment 
(selection bias) 
Unclear risk Not Specified 
Blinding of participants and 
researchers (performance 
bias) 
High risk 
Participants aware of dietary group after first check-up (3 months into 1-year 
trial) - No description of blinding by researchers. 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
High Risk 
Dropout rate >25% in vegan group after 1 year.  Intention-to-treat (ITT) not 
used 
Selective reporting (reporting 
bias) 
Unclear risk Protocol not available 
Other bias High Risk CRP appears significantly higher in control group at baseline. 
Kahleova et al. (73) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear risk Stated to be randomized, no details of randomisation method given 
Allocation concealment 
(selection bias) 
Unclear risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
Unclear risk Not possible to blind personnel, unclear if patients blinded 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
Low risk 16% drop out, but similar between groups and ITT used 
Selective reporting (reporting 
bias) 
Unclear risk 
Protocol available, but insufficient information to determine if all outcomes 
reported 
Other bias High risk Smoking higher in Control group at baseline 
Hunt & Roughead. (81) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear risk Stated to be randomized, no details of randomisation method given 
 
Allocation concealment 
(selection bias) 
Unclear Risk Not stated 
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Supplemental Table 4 – Continued 
 
 
Blinding of participants and 
researchers (performance 
bias) 
High Risk 
Not possible to blind researchers. Not possible to blind participants (cross-
over) which may have affected performance in different arms 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
Low risk Nil drop out 
Selective reporting (reporting 
bias) 
Unclear risk Protocol not available 
Other bias High Risk Nil washout period 
Kjeldsen-Kragh et al.  (74, 75) 1 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear Risk Stated to be randomized, no details of randomisation method given 
Allocation concealment 
(selection bias) 
Unclear Risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
High risk 
Single blind trial - Participants aware of dietary group after first check-up (3 
months into 1-year trial). 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Clinicians/GP's blinded + outcomes unlikely to be influenced by blinding 
(blood bio-markers) 
Incomplete outcome data 
(attrition bias) 
High risk 30% drop out (even though ITT used and similar between groups) 
Selective reporting (reporting 
bias) 
Unclear Risk The study protocol is not available 
Other bias High Risk 
Insufficient baseline data reported to determine differences between groups + 
substantial difference in kJ intake between interventions and control 
Macknin et al.  (76) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Low Risk 
Randomized using an SAS computer program 1:1 in blocks of 4 families 
stratified by the child’s age group 
(age strata 9-13 years vs 14-18 years) 
Allocation concealment 
(selection bias) 
Unclear risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
Unclear risk Not stated 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
High Risk >10% drop out, both in intervention group, no ITT 
Selective reporting (reporting 
bias) 
Low Risk 
The study protocol is available and all pre-specified outcomes of interest to the 
review have been reported in the pre specified way 
Other bias High Risk Baseline CRP and IL-6 does not appear to be similar. 
Nenonen et al. (77) 
Bias Authors’ judgment Support for judgment 
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Supplemental Table 4 – Continued 
 
 
Random sequence generation 
(selection bias) 
Unclear risk Stated to be randomized, no details of randomisation method given 
Allocation concealment 
(selection bias) 
Unclear risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
Unclear risk Not stated 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
High risk higher drop out in intervention, related to intervention 
Selective reporting (reporting 
bias) 
Unclear risk Protocol not available 
Other bias Unclear risk Baseline CRP between groups unclear 
Richter et al (78) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear Risk Not stated 
Allocation concealment 
(selection bias) 
Unclear Risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
High risk 
Would not be possible to blind participants or personnel as food was provided. 
Whilst this may not have affected measures, it may have affected participant 
behaviour during intervention and control periods 
Blinding of outcome 
assessment (detection bias) 
Low risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
Low risk No missing outcome data 
Selective reporting (reporting 
bias) 
Unclear Risk The study protocol not available 
Other bias Low risk 4-week washout period, 
   
Sköldstam et al. (80) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear Risk Not stated 
Allocation concealment 
(selection bias) 
Unclear Risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
Unclear Risk Not stated 
Blinding of outcome 
assessment (detection bias) 
Low Risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
Low risk <5% drop out rate 
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Supplemental Table 4 - Continued 
Selective reporting (reporting 
bias) 
Unclear risk Protocol not described 
Other bias High Risk Some bio-markers not comparable at baseline 
   
Sköldstam (79) 
Bias Authors’ judgment Support for judgment 
Random sequence generation 
(selection bias) 
Unclear Not stated 
Allocation concealment 
(selection bias) 
Unclear Risk Not stated 
Blinding of participants and 
researchers (performance 
bias) 
high risk 
Not possible to blind researchers. Not possible to blind participants (pre-post) 
which may have affected performance in different arms 
Blinding of outcome 
assessment (detection bias) 
Low Risk 
Not stated - although outcomes unlikely to be influenced by blinding (blood 
bio-markers) 
Incomplete outcome data 
(attrition bias) 
unclear risk <10%, but unclear at which time pts dropped out 
Selective reporting (reporting 
bias) 
Unclear Risk Protocol not described 
Other bias Unclear Risk Base line data not reported 
   
CRP, C-Reactive Protein; ITT, intention to treat; SAS, Statistical Analysis System. 
1 Kjeldsen-Kragh et al 1995 and 1991 - same participants/study, different outcomes reported 
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Supplemental Figure 7. Risk of bias graph: review authors’ judgments about each risk of 
bias item presented as percentages across all included studies. 
 
 
 
